Carbidopa-Levodopa Articles

Abbott reports positive findings from Ph III Parkinson's disease study

10 June 2011

US FDA questions safety of Novartis/Orion’s Stalevo due to possible increased cardiovascular risk

23 August 2010

Drug candidates in pipeline offer potential for Parkinson's disease market, says Frost & Sullivan

9 December 2009

Azur buys four drugs from UCB

19 January 2009

KV resolves a handful of legal matters

20 September 2004

FDA approves Schwarz Pharma's Parcopa

13 September 2004

Merck backs off Impax lawsuit?

14 April 2003

Bristol-Myers Squibb buys DuPont Pharma for $7.8 billion

11 June 2001

Roche And DuPont In Parkinson's Link-Up

6 August 1998

Forecasts For Global CNS Growth

23 June 1998

DuPont Buys Out Merck's Stake In JV For $2.6 Billion

21 May 1998

DuPont Merck And Elan Parkinson's Drugs Co-Promotion Deal

10 July 1997

Sandoz To License Orion Parkinson's Drug

4 March 1996

WEST POINT EXPANDS PRODUCT LINE

9 May 1994

DUPONT MERCK TO PROMOTE LAMICTAL

16 August 1993

THREE-WAY GENERIC AGREEMENT

31 May 1993

WORLD CNS MARKET IS LARGE AND FRAGMENTED

22 February 1993

TEVA AND DU PONT MERCK SALES DEAL

12 October 1992

Showing 1-18 of 18 articles

Go to beginningPrevious
  • 1
NextGo to end